Inpatient Rsv-Management 2016-2022: Epidemiology and Adherence to A Bronchiolitis Treatment Standard at a German University Children's Hospital.
Solvej HeidtmannYeliz BaltaciSascha MeyerMichael ZemlinRhoikos FurtwänglerJuergen RisslandArne SimonPublished in: Klinische Padiatrie (2024)
This audit confirms the strong impact of public preventive measures directed against SARS-CoV-2 transmission on RSV epidemiology. Few weeks after easing public COVID-19 restrictions (summer 2021), RSV inpatient cases rapidly increased, lasting until Dec. 2021. The audit of bronchiolitis management revealed surprisingly low adherence to the internal guidance, despite a face-to-face educational session with the attending pediatricians in Oct. 2021. Low adherence resulted in an unnecessary exposure of RSV patients to systemic medications of questionable benefit including antibiotics.
Keyphrases
- respiratory syncytial virus
- sars cov
- mental health
- healthcare
- respiratory tract
- end stage renal disease
- acute care
- palliative care
- ejection fraction
- coronavirus disease
- chronic kidney disease
- risk factors
- newly diagnosed
- respiratory syndrome coronavirus
- peritoneal dialysis
- young adults
- glycemic control
- prognostic factors
- adverse drug
- heat stress
- optical coherence tomography
- type diabetes
- single cell
- emergency department
- high intensity
- diabetic retinopathy
- combination therapy
- skeletal muscle
- insulin resistance
- weight loss
- gestational age
- electronic health record